Snipr Biome (private company)

See something wrong or missing? Let us know
Offices:
Copenhagen
Registration number:
38871277
Category:
Biotech
Business model:
B2B
Investors:
we tracked 4 investors
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 1 transaction

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

SNIPR manages CRISPR-Cas9 gene editing with the microbiome. The company’s proprietary CRISPR-Cas tech platform is used to selectively and precisely eradicate target bacterial, but still leave the patient’s microbial community alone.

Companies with similar profile to Snipr Biome:

CompanyCriteria
Sweden OxThera
55%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: LSP (Life Sciences Partners)
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark NMD Pharma
55%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Lundbeckfond Ventures
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden BoneSupport
45%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Lundbeckfond Ventures
  • Total raised in a similar range: 10M+ USD
Denmark IO Biotech
45%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Lundbeckfond Ventures
  • Total raised in a similar range: 10M+ USD
Sweden Glo
44%
  • Similar business models: B2B
  • At least one vc investor: Wellington Partners
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Finland Glucostratus (Mendor)
44%
  • Similar business models: B2B
  • At least one vc investor: LSP (Life Sciences Partners)
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Norway Agrinos
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Orphazyme
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Norway Oncoinvent
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Aprea Therapeutics
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden ITBMed
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Iceland Alvotech
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark RSP Systems
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Galecto Biotech
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Finland Mobidiag
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Norway BerGenBio
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Tonsser
33%
  • At least one vc investor: Wellington Partners
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Spotify
33%
  • At least one vc investor: Wellington Partners
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Finland TILT Biotherapeutics
33%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Finland Optomed
33%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes